<div class="docx-content">
<h1 class="text-2xl font-bold mt-8 mb-4"><strong>Rickettsial Diseases</strong></h1><ul><li><em>Rickettsia</em> are small, obligate intracellular Gram-negative coccobacilli</li><li>Transmitted by arthropod vectors (ticks, lice, fleas, mites). NB humans main host in R<strong><em>. prowazekii</em></strong></li><li>They are divided into three groups:</li><li><strong>Spotted Fever Group (SFG)</strong></li><li><strong>Typhus Group</strong></li><li><strong>Scrub Typhus</strong> (caused by <em>Orientia tsutsugamushi</em>, closely related, often included with rickettsial diseases).</li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>I. Pathogenesis &amp; General Clinical Features</strong></h2><ul><li><strong>Target cells:</strong> Primarily <strong>vascular endothelial cells</strong>, causing endothelial injury, vasculitis, microvascular leakage → rash, oedema, organ dysfunction.</li><li><strong>Common features (incubation 5–10 days):</strong><ul><li>Fever, headache, malaise, myalgia, nausea, vomiting.</li><li><strong>Rash:</strong> maculopapular, petechial, or vesicular; distribution varies by disease.</li><li><strong>Eschar:</strong> dark necrotic scab at bite site, typical in SFG and scrub typhus.</li></ul></li><li><strong>Complications (severe disease):</strong> pneumonitis, myocarditis, meningoencephalitis, renal/hepatic failure, DIC.</li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>II. Spotted Fever Group (SFG)</strong></h2><p>Over 20 species cause human disease. Transmission mainly by hard ticks, occasionally mites or fleas.</p><p><strong>Key species and diseases</strong></p><ul><li><em>R. rickettsii</em> – Rocky Mountain Spotted Fever (RMSF, Americas).</li><li><em>R. conorii</em> – Mediterranean Spotted Fever (Southern Europe, Africa, Middle East).</li><li><em>R. africae</em> – African Tick Bite Fever (sub-Saharan Africa, Caribbean).</li><li><em>R. akari</em> – Rickettsialpox (urban rodents, mites; NY, Europe, Korea, SA).</li><li><em>R. australis</em> – Queensland tick typhus (Australia).</li><li><em>R. sibirica</em> – North Asian tick typhus.</li><li><em>R. slovaca, R. raoultii</em> – Tick-borne lymphadenopathy (TIBOLA/SENLAT).</li><li><em>R. felis</em> – Flea-borne spotted fever (global).</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Clinical Presentation</strong></h3><ul><li><strong>Rocky Mountain Spotted Fever (RMSF, <em>R. rickettsii</em>)</strong><ul><li>Severe, life-threatening; untreated CFR up to 20–80%.</li><li>Sudden fever, headache, myalgia, abdo pain.</li><li><strong>Rash:</strong> starts wrists/ankles → centripetal spread; may involve palms/soles; evolves to petechiae. Absent in 5–17%.</li><li>Complications: gangrene, encephalitis, ARDS, renal failure, neurologic sequelae.</li></ul></li><li><strong>Mediterranean Spotted Fever (<em>R. conorii</em>)</strong><ul><li>Fever, rash, tender lymphadenopathy.</li><li><strong>Eschar in ~70%.</strong> Less severe than RMSF, but severe disease possible.</li></ul></li><li><strong>African Tick Bite Fever (<em>R. africae</em>)</strong><ul><li>Usually mild. Fever, myalgia, headache, lymphadenopathy.</li><li>Multiple eschars common. Rash scant or vesicular.</li></ul></li><li><strong>Rickettsialpox (<em>R. akari</em>)</strong><ul><li>Mild, self-limiting.</li><li>Fever, malaise, conjunctivitis, hepatitis.</li><li><strong>Eschar at mite bite site</strong> precedes a vesicular rash resembling chickenpox. No palm/sole involvement.</li></ul></li><li><strong>TIBOLA/SENLAT (e.g. <em>R. slovaca</em>)</strong><ul><li><strong>Scalp eschar + tender cervical lymphadenopathy.</strong> Rash uncommon.</li></ul></li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Diagnosis</strong></h3><ul><li><strong>Clinical suspicion</strong> crucial </li><li><strong>PCR</strong> (blood, eschar, biopsy).</li><li><strong>IHC / DFA</strong> on skin biopsy.</li><li><strong>Serology (IFA, ELISA)</strong> retrospective confirmation; cross-reactivity common.</li><li><strong>Culture</strong> possible but restricted to reference labs.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Treatment</strong></h3><ul><li><strong>Doxycycline</strong> 100 mg twice daily (7–10).</li><li><strong>Children/pregnancy:</strong> doxycycline still recommended if severe.</li><li><strong>Alternatives:</strong> chloramphenicol (historical; less effective, safety concerns); macrolides (e.g. azithromycin) in mild disease or pregnancy.</li><li><strong>Prevention:</strong> tick avoidance (repellents, clothing). No licensed vaccines.</li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>III. Typhus Group</strong></h2><ul><li><strong>Epidemic (louse-borne) typhus</strong> – <em>R. prowazekii</em></li><li><strong>Endemic (murine) typhus</strong> – <em>R. typhi</em></li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Epidemiology &amp; Transmission</strong></h3><ul><li><strong>Epidemic typhus (<em>R. prowazekii</em>)</strong><ul><li>Vector: body louse (<em>Pediculus humanus corporis</em>).</li><li>Reservoir: humans; also flying squirrels in N. America.</li><li>Outbreaks in poverty, conflict, refugee settings.</li><li><strong>Brill–Zinsser disease:</strong> recrudescence years later.</li></ul></li><li><strong>Murine typhus (<em>R. typhi</em>)</strong><ul><li>Vector: rat fleas (<em>Xenopsylla cheopis</em>), cat fleas (via their faeces)</li><li>Reservoir: rodents, cats, dogs.</li><li>Worldwide; esp. port cities, subtropics (US, Mediterranean, Asia).</li></ul></li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Clinical Features</strong></h3><ul><li><strong>Epidemic, tick-borne typhus</strong><ul><li>Sudden fever, severe headache, myalgia, delirium.</li><li><strong>Rash:</strong> day 4–7, trunk first → centrifugal spread; spares face/palms/soles.</li><li>No eschar.</li><li>Severe cases: myocarditis, renal failure, CNS disease.</li><li>CFR up to 30% untreated (higher in elderly).</li></ul></li><li><strong>Endemic, murine typhus</strong><ul><li>Milder, gradual onset.</li><li>Rash in ~50% (macular). </li><li>No eschar.</li><li>Complications: interstitial pneumonitis, nephritis, myocarditis, meningoencephalitis, ocular disease.</li><li>CFR 1–4%.</li></ul></li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Diagnosis</strong></h3><ul><li>Clinical suspicion.</li><li>PCR on blood/tissue.</li><li>IHC on biopsy.</li><li>Serology – retrospective confirmation.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Treatment</strong></h3><ul><li><strong>Doxycycline</strong> (7 days; sometimes single dose for epidemic typhus in mass outbreaks).</li><li>Alternatives: chloramphenicol, tetracycline.</li><li>Ineffective: β-lactams, aminoglycosides, sulfonamides.</li><li><strong>Prevention:</strong> delousing; rodent/flea control.</li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>IV. Scrub Typhus (<em>Orientia tsutsugamushi</em>)</strong></h2><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Epidemiology</strong></h3><ul><li>Vector: larval trombiculid mites (chiggers).</li><li>Reservoir: rodents; mites transmit transovarially.</li><li>Geography: “tsutsugamushi triangle” – Asia-Pacific, northern Australia, Pacific Islands.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Clinical Features</strong></h3><ul><li>Acute febrile illness (fever, headache, myalgia).</li><li><strong>Eschar common (~50%).</strong></li><li>Rash variable.</li><li>Severe: pneumonitis, myocarditis, meningoencephalitis, multi-organ failure.</li><li>Deafness is a characteristic feature in some cases.</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Diagnosis</strong></h3><ul><li>Clinical (fever + eschar in endemic area).</li><li>PCR (blood, eschar swab, biopsy).</li><li>Serology (retrospective)</li></ul><h3 class="text-lg font-semibold mt-6 mb-3"><strong>Treatment</strong></h3><ul><li><strong>Doxycycline</strong> – rapid defervescence.</li><li><strong>Azithromycin</strong> – effective, esp. in pregnancy, children, doxycycline-resistant strains.</li><li>Alternatives: chloramphenicol, rifampicin.</li></ul><h1 class="text-2xl font-bold mt-8 mb-4"><strong>Key Exam Points (FRCPath Part 2)</strong></h1><ul><li><strong>Rickettsiae infect endothelium → vasculitis → rash/organ involvement.</strong></li><li><strong>SFG:</strong> rash often centripetal, eschars common.</li><li><strong>Typhus group:</strong> no eschars; epidemic typhus has trunk-first centrifugal rash.</li><li><strong>Scrub typhus:</strong> eschar + deafness; endemic Asia-Pacific.</li><li><strong>Doxycycline is the treatment of choice for ALL rickettsioses</strong> </li><li><strong>Don’t delay treatment while awaiting confirmation.</strong></li><li>Diagnosis usually retrospective by serology; PCR on eschar/blood helpful acutely.</li></ul>
</div>